|
WO0130757A1
|
|
Drug discharge pump inhibitors
|
|
WO0121623A1
|
|
7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
|
|
WO0036489A2
|
|
Pattern recognition oriented cluster analysis
|
|
AU2902999A
|
|
A novel method for substrate detection
|
|
AU2337599A
|
|
Efflux pump inhibitors
|
|
US6228842B1
|
|
Pacidamycins produced by Streptomyces coeruleorubidus
|
|
AU9785698A
|
|
Fungal efflux pump inhibitors
|
|
US6399629B1
|
|
Efflux pump inhibitors
|
|
US6204279B1
|
|
Peptidomimetic efflux pump inhibitors
|
|
WO9846566A1
|
|
IMPROVED β-LACTAM ANTIBIOTICS
|
|
US6245746B1
|
|
Efflux pump inhibitors
|
|
US6114310A
|
|
Efflux pump inhibitors
|
|
AU5903398A
|
|
Staphylococcus aureus histidine protein kinase essential genes
|
|
US6030965A
|
|
Cephalosporin antibiotics
|
|
US6025352A
|
|
Cephalosporin antibiotics
|
|
EP0920530A1
|
|
Screening methods using microbial strain pools
|
|
US5962249A
|
|
Sized-based marker identification technology
|
|
CA2240499A1
|
|
Size-based marker identification technology
|
|
LT96154A
|
|
Cephalosporin antibiotics
|
|
NZ500512A
|
|
Cephalosporin for treating beta-lactam antibiotic resistant bacteria (such as S. aureus, E. faecium or E. faecalis) or PBP2a-producing bacteria
|
